Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with Type 1 diabetes mellitus: A 5-year prospective study

Journal of Endocrinological Investigation

Volumn 34, Issue 5, 2011, Pages 340-344

  Alonso, N ^a   Granada, M L ^a   Soldevila, B ^a   Salinas, I ^a   Joaquin, C ^a   Reverter, J L ^a   Junca J ^a   Martinez Caceres E M ^a   Sanmarti A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cobalamin; Gastrin; Parietal cell antibodies; Pepsinogen; Type 1 diabetes mellitus

Indexed keywords

CELL ANTIBODY; COBALAMIN; GASTRIN; HEMOGLOBIN; PEPSINOGEN I;

ADULT; ARTICLE; AUTOIMMUNE GASTRITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PROTEIN BLOOD LEVEL; STOMACH PARIETAL CELL; UNIVERSITY HOSPITAL;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HUMANS; MALE; PARIETAL CELLS, GASTRIC; PEPSINOGEN A; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79960202452     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7104     Document Type: Article

References (21)

1. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995, 12: 622-7.
2. Vitoria JC, Castaño L, Rica I, Bilbao JR, Arrieta A, García-Masdevall MD. Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers. J Pediatr Gastroenterol Nutr 1998, 27: 47-52. (Pubitemid 28293024)
3. De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 2008, 93: 363-71. (Pubitemid 351240803)
4. Barker JM. Clinical review. Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 2006, 91: 1210-7.
5. De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin- dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1999, 84: 4062-7. (Pubitemid 30644195)
6. Irvine WJ, Cullen DR. Natural history of autoimmune achlorhydric atrophic gastritis. Lancet 1974, 31: 482-5.
7. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997, 337: 1441-8. (Pubitemid 127777478)
8. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol 1988, 90: 442-5
9. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991, 186: 109-16.
10. Alonso N, Granada ML, Salinas I, et al. Serum pepsinogen I. An early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2005, 90: 5254-8. (Pubitemid 41262283)
11. Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol 1989, 42: 1092-5. (Pubitemid 19255624)
12. Riley WJ, Toskes PP, Maclaren NK, Silverstein JH. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes 1982, 31: 1051-5.
13. Samloff IM, Varis K, lhamaki T, Siurala M, Rotter Jl. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982, 83: 204-09.
14. Alonso N, Granada ML, Salinas I, et al. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur J Endocrinol 2007, 157: 763-9.
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20: 1161-81.
16. De Block CE, De Leeuw IH, Bogers JJ, et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003, 26: 82-8. (Pubitemid 36928998)
17. Sipponen P, Valle J, Varis K, Kekki M, Ihamäki T, Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990, 25: 513-9. (Pubitemid 20208216)
18. Ungar B, Stocks AE, Martin FI, Whittingham S, Mackay IR. Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anaemia in diabetes mellitus. Lancet 1968, 2: 415-7.
19. Davis RE, McCann VJ, Stanton KG. Type 1 diabetes and latent pernicious anaemia. Med J Austr 1992, 156: 160-2.
20. De Block CE, Colpin G, Thielemans K, et al. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. Diabetes Care 2004, 27: 1387-93. (Pubitemid 38679988)
21. Hirota WK, Zuckerman MJ, Adler DG, et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006, 63: 570-80.